KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Receivables (2016 - 2025)

Historic Receivables for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $748.3 million.

  • Charles River Laboratories International's Receivables fell 382.95% to $748.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $748.3 million, marking a year-over-year decrease of 382.95%. This contributed to the annual value of $739.2 million for FY2024, which is 829.69% down from last year.
  • Charles River Laboratories International's Receivables amounted to $748.3 million in Q3 2025, which was down 382.95% from $780.4 million recorded in Q2 2025.
  • Over the past 5 years, Charles River Laboratories International's Receivables peaked at $820.5 million during Q3 2023, and registered a low of $617.8 million during Q1 2021.
  • Its 5-year average for Receivables is $752.2 million, with a median of $772.9 million in 2025.
  • Per our database at Business Quant, Charles River Laboratories International's Receivables soared by 2139.21% in 2021 and then crashed by 829.69% in 2024.
  • Over the past 5 years, Charles River Laboratories International's Receivables (Quarter) stood at $657.6 million in 2021, then increased by 16.14% to $763.7 million in 2022, then rose by 5.56% to $806.1 million in 2023, then fell by 8.3% to $739.2 million in 2024, then increased by 1.23% to $748.3 million in 2025.
  • Its last three reported values are $748.3 million in Q3 2025, $780.4 million for Q2 2025, and $772.9 million during Q1 2025.